Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma

Keyphrases

• Older Adults 100%
• Treatment Burden 100%
• Newly Diagnosed multiple Myeloma 100%
• First Year 45%
• Adjusted Odds Ratio 36%
• Multiple Myeloma 27%
• Newly Diagnosed 18%
• Surveillance Epidemiology 18%
• Tailored Intervention 18%
• Substantial Burden 18%
• Linked Database 18%
• Hematological Malignancies 9%
• Comorbidity 9%
• Logistic Regression 9%
• Medicare 9%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 9%
• Charlson Comorbidity Index 9%
• Myeloma 9%
• Bone Disease 9%
• Provided Support 9%
• Poor Performance Status 9%
• Healthcare 9%
• Oncology 9%
• Physician Visits 9%
• Acute Care 9%
• Treatment Advances 9%
• Patient-centered Care 9%
• End-organ Damage 9%
• Care Relationship 9%
• Outpatient Visits 9%
• Non-oncology 9%

Medicine and Dentistry

• Multiple Myeloma 100%
• Odds Ratio 80%
• Health Care 40%
• Hematologic Malignancy 20%
• Patient Care 20%
• Medicare 20%
• Logistic Regression Analysis 20%
• Cohort Effect 20%
• Surveillance, Epidemiology, and End Results 20%
• Charlson Comorbidity Index 20%
• Oncology 20%
• Outpatient 20%
• Autologous Stem Cell Transplantation 20%
• Emergency Care 20%
• Myeloma 20%
• End Organ Damage 20%
• Comorbidity 20%
• Bone Disease 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Multiple Myeloma 100%
• Comorbidity 40%
• Hematologic Malignancy 20%
• Myeloma 20%
• Bone Disease 20%